Press releases
- Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
- Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
- Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
- Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024
- Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting
More ▼
Key statistics
On Thursday, Apyx Medical Corp (BOV:DUS) closed at 1.33, -6.34% below its post-IPO high of 1.42, set on Apr 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.27 |
---|---|
High | 1.33 |
Low | 1.27 |
Bid | 1.30 |
Offer | 1.37 |
Previous close | 1.30 |
Average volume | 0.00 |
---|---|
Shares outstanding | 34.64m |
Free float | 28.44m |
P/E (TTM) | -- |
Market cap | 48.50m USD |
EPS (TTM) | -0.5403 USD |
Data delayed at least 15 minutes, as of May 02 2024 18:31 BST.
More ▼